Review Finds Major Weaknesses in Evidence Base for Covid-19 Antibody Tests
A report in the British Medical Journal finds that evidence does not support continued use of existing point-of-care tests for covid-19.
Read MorePosted by Laurie Bonner | Jul 2, 2020 | Covid 19, Immunoassay Reagents & test Kits |
A report in the British Medical Journal finds that evidence does not support continued use of existing point-of-care tests for covid-19.
Read MorePosted by Laurie Bonner | Jul 2, 2020 | Covid 19, Uncategorized |
Pooled testing addresses the problem of having too few test kits available.
Read MorePosted by Laurie Bonner | Jul 1, 2020 | Covid 19, Uncategorized |
Binx health’s molecular io platform will be combined with Sherlock CRISPR technology to enable rapid testing for SARS-CoV-2 in retail settings
Read MorePosted by Laurie Bonner | Jul 1, 2020 | Covid 19, Molecular Diagnostics |
The T2SARS-CoV-2 Panel will run on the FDA-cleared T2Dx instrument.
Read MorePosted by Laurie Bonner | Jul 1, 2020 | Covid 19, Uncategorized |
Clinical labs struggle to match tests and testing strategies to the challenges of the covid-19 pandemic.
Read More